Silver One Resources Inc. (SLVRF)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	55	35	33	43	69	106
Market Cap Growth	26.45%	3.63%	-21.74%	-38.22%	-34.83%	148.62%
Enterprise Value	53	32	32	39	59	94
Last Close Price	0.23	0.13	0.14	0.19	0.33	0.53
PB Ratio	1.90	1.20	1.27	1.79	2.79	4.07
P/TBV Ratio	1.90	1.20	1.27	1.79	2.79	4.07
Debt / Equity Ratio	-	-	-	0	0.01	0.01
Quick Ratio	17.06	7.94	13.74	16.25	17.30	13.30
Current Ratio	18.59	8.45	22.70	21.95	18.60	19.02
Return on Equity (ROE)	-7.23%	-7.42%	-9.56%	-12.88%	-17.18%	-8.20%
Return on Assets (ROA)	-3.74%	-3.78%	-4.42%	-5.40%	-5.29%	-3.45%
Return on Capital (ROIC)	-3.83%	-3.89%	-4.49%	-5.46%	-5.40%	-3.55%
Earnings Yield	-3.54%	-5.70%	-7.28%	-7.10%	-6.34%	-1.53%
FCF Yield	-5.72%	-8.62%	-8.23%	-12.16%	-8.33%	-4.10%
Buyback Yield / Dilution	-8.35%	-9.15%	-10.48%	-4.27%	-11.88%	-44.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.